[French Society for Surgical Oncology (SFCO) guidelines for the management of surgical oncology in the pandemic context of COVID 19].
作者信息
Classe Jean-Marc, Dolivet Gilles, Evrard Serge, Ferron Gwenael, Lécuru Fabrice, Leufflen Lea, Rivoire Michel, Sgarbura Olivia
机构信息
Université de Nantes, institut de cancérologie de l'Ouest, département de chirurgie oncologique, boulevard du Professeur-J.-Monod, 44805 Saint-Herblain, France.
Institut de cancérologie de Lorraine, département de chirurgie oncologique, UMR 7039 CRAN CNRS Nancy, Nancy, France.
出版信息
Bull Cancer. 2020 May;107(5):524-527. doi: 10.1016/j.bulcan.2020.03.010. Epub 2020 Apr 6.
Abstract
摘要
相似文献
1
[French Society for Surgical Oncology (SFCO) guidelines for the management of surgical oncology in the pandemic context of COVID 19].[法国外科肿瘤学会（SFCO）关于COVID-19大流行背景下外科肿瘤管理的指南]
Bull Cancer. 2020 May;107(5):524-527. doi: 10.1016/j.bulcan.2020.03.010. Epub 2020 Apr 6.
2
[COVID 19 and cancer: What are the consequences of the cancer care reorganization?].[新冠疫情与癌症：癌症护理重组会带来哪些后果？]
Bull Cancer. 2020 May;107(5):538-540. doi: 10.1016/j.bulcan.2020.04.001. Epub 2020 Apr 23.
3
Cancer surgery in a time of COVID-19: Many questions, few certainties.新冠疫情时期的癌症手术：问题众多，确定性寥寥。
Eur J Surg Oncol. 2020 Jun;46(6):1196-1197. doi: 10.1016/j.ejso.2020.04.046. Epub 2020 Apr 30.
4
[COVID-19 and cancers. Summary of French guidelines from medical societies and their evolution].[新型冠状病毒肺炎与癌症。法国医学协会指南总结及其演变]
Bull Cancer. 2020 May;107(5):521-523. doi: 10.1016/j.bulcan.2020.04.008.
5
Cancer surgery sustainability in the light of COVID-19 pandemic.新冠疫情背景下癌症手术的可持续性
Eur J Surg Oncol. 2020 Jun;46(6):1174-1175. doi: 10.1016/j.ejso.2020.05.018.
6
Safety of cancer surgery during the COVID-19 pandemic.2019冠状病毒病大流行期间癌症手术的安全性。
Br J Surg. 2020 Aug;107(9):e314-e315. doi: 10.1002/bjs.11767. Epub 2020 Jun 22.
7
Avoiding collateral mortality in a pandemic - time to change our mindset in surgical oncology.避免大流行中的附带死亡——是时候改变我们在外科肿瘤学中的思维模式了。
Nat Rev Clin Oncol. 2020 Jul;17(7):383-385. doi: 10.1038/s41571-020-0383-1.
8
Surgical oncology at the time of COVID-19 outbreak.2019冠状病毒病疫情期间的外科肿瘤学
J Surg Oncol. 2020 Aug;122(2):115-116. doi: 10.1002/jso.25975. Epub 2020 Jun 4.
9
Providing cancer surgery in the COVID-19 crisis.在新冠疫情危机期间提供癌症手术服务。
Br J Surg. 2020 Jul;107(8):e248. doi: 10.1002/bjs.11693. Epub 2020 May 14.
10
COVID-19 Guideline Modifications as CMS Announces "Opening Up America Again": Comments from the Society of Surgical Oncology.随着美国医疗保险和医疗补助服务中心宣布“让美国再次开放”，COVID-19指南的修改：来自外科肿瘤学会的评论
Ann Surg Oncol. 2020 Jul;27(7):2111-2113. doi: 10.1245/s10434-020-08565-9. Epub 2020 May 6.
引用本文的文献
1
Developing Cancer Quality of Care Indicators to Quantify the Impact of a Global Destabilization of the Care System (COLLAT-COVID).制定癌症护理质量指标以量化全球护理系统不稳定（COLLAT-COVID）的影响。
Cancers (Basel). 2025 May 16;17(10):1680. doi: 10.3390/cancers17101680.
2
Two-stage multi-objective optimization for ICU bed allocation under multiple sources of uncertainty.多源不确定性下 ICU 床位分配的两阶段多目标优化。
Sci Rep. 2023 Nov 2;13(1):18925. doi: 10.1038/s41598-023-45777-x.
3
Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic.困难时期的癌症护理组织：对COVID-19大流行期间专家指南及其实施情况的范围审查
Crit Rev Oncol Hematol. 2022 May;173:103656. doi: 10.1016/j.critrevonc.2022.103656. Epub 2022 Mar 23.
4
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL).新冠疫情第一波对里昂大学医院癌症研究所（IC-HCL）的影响。
Cancers (Basel). 2021 Dec 22;14(1):29. doi: 10.3390/cancers14010029.
5
[COVID-19 and patients with cancer: Experiment of a French comprehensive cancer center].[新冠病毒肺炎与癌症患者：法国一家综合性癌症中心的试验]
Bull Cancer. 2021 Jun;108(6):571-580. doi: 10.1016/j.bulcan.2021.02.008. Epub 2021 Apr 8.
6
Continuing cancer surgery through the first six months of the COVID-19 pandemic at an academic university hospital in India: A lower-middle-income country experience.在印度的一所学术大学附属医院，在 COVID-19 大流行的头六个月继续进行癌症手术：一个中低收入国家的经验。
J Surg Oncol. 2021 Apr;123(5):1177-1187. doi: 10.1002/jso.26419. Epub 2021 Feb 10.
7
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).实体瘤癌症患者 2019 年冠状病毒病（COVID-19）严重程度和死亡率的危险因素以及该疾病对癌症治疗的影响：一项法国全国性队列研究（GCO-002 CACOVID-19）。
Eur J Cancer. 2020 Dec;141:62-81. doi: 10.1016/j.ejca.2020.09.035. Epub 2020 Oct 8.
8
[COVID-19 and cancers. Summary of French guidelines from medical societies and their evolution].[新型冠状病毒肺炎与癌症。法国医学协会指南总结及其演变]
Bull Cancer. 2020 May;107(5):521-523. doi: 10.1016/j.bulcan.2020.04.008.
本文引用的文献
1
Minimally Invasive Surgery and the Novel Coronavirus Outbreak: Lessons Learned in China and Italy.微创手术与新型冠状病毒疫情：中国和意大利的经验教训
Ann Surg. 2020 Jul;272(1):e5-e6. doi: 10.1097/SLA.0000000000003924.
2
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.新冠疫情期间稀缺医疗资源的公平分配
N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23.
3
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.宿主对重症新型冠状病毒肺炎的易感性及宿主风险评分的建立：武汉以外地区487例病例的研究结果
Crit Care. 2020 Mar 18;24(1):108. doi: 10.1186/s13054-020-2833-7.
4
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.意大利伦巴第大区新冠疫情期间的重症监护利用情况：应急响应中的早期经验与预测
JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.
5
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
Zotero 插件